Benoxinate or oxybuprocaine
- Level
- Commodity
- Parent
- 51271900
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51271904This classification denotes an anesthetic agent with the molecular formula C17H28N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AXQ0JYM303, chemically known as benzoic acid, 4-amino-3-butoxy-, 2-(diethylamino)ethyl ester (7ci,8ci,9ci) but generally known as benoxinate, which bears US NIH Compound Identifier 4633. Benoxinate most often comes in base and hydrochloride forms. European Medicines Agency schedules Oxybuprocaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09557MIG. The term OXYBUPROCAINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules benoxinate in its Anatomical Therapeutic Chemical (ATC) Classification. Benoxinate or oxybuprocaine bears US NLM identifiers UMLS ID C0053114 and NCI Concept Code C72176. SMILES: CCCCOC1=C(C=CC(=C1)C(=O)OCCN(CC)CC)N.
Same parent
Under 51271900 · 24Activities that produce or sell this
KBLI · 8Inherited from family 51270000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.